Advanced search
1 file | 673.12 KB Add to list

Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA

Pieter De Visschere (UGent) , Nicolaas Lumen (UGent) , Piet Ost (UGent) , Karel Decaestecker (UGent) , EVA PATTYN (UGent) and Geert Villeirs (UGent)
(2017) CLINICAL RADIOLOGY. 72(1). p.23-32
Author
Organization
Keywords
MULTIPARAMETRIC MRI, REFERENCE-STANDARD, GUIDED BIOPSIES, SCORING SYSTEM, LOCALIZATION, METAANALYSIS, COHORT, PERFORMANCE, VALIDATION, GUIDELINES

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 673.12 KB

Citation

Please use this url to cite or link to this publication:

MLA
De Visschere, Pieter et al. “Dynamic Contrast-enhanced Imaging Has Limited Added Value over T2-weighted Imaging and Diffusion-weighted Imaging When Using PI-RADSv2 for Diagnosis of Clinically Significant Prostate Cancer in Patients with Elevated PSA.” CLINICAL RADIOLOGY 72.1 (2017): 23–32. Print.
APA
De Visschere, Pieter, Lumen, N., Ost, P., Decaestecker, K., PATTYN, E., & Villeirs, G. (2017). Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. CLINICAL RADIOLOGY, 72(1), 23–32.
Chicago author-date
De Visschere, Pieter, Nicolaas Lumen, Piet Ost, Karel Decaestecker, EVA PATTYN, and Geert Villeirs. 2017. “Dynamic Contrast-enhanced Imaging Has Limited Added Value over T2-weighted Imaging and Diffusion-weighted Imaging When Using PI-RADSv2 for Diagnosis of Clinically Significant Prostate Cancer in Patients with Elevated PSA.” Clinical Radiology 72 (1): 23–32.
Chicago author-date (all authors)
De Visschere, Pieter, Nicolaas Lumen, Piet Ost, Karel Decaestecker, EVA PATTYN, and Geert Villeirs. 2017. “Dynamic Contrast-enhanced Imaging Has Limited Added Value over T2-weighted Imaging and Diffusion-weighted Imaging When Using PI-RADSv2 for Diagnosis of Clinically Significant Prostate Cancer in Patients with Elevated PSA.” Clinical Radiology 72 (1): 23–32.
Vancouver
1.
De Visschere P, Lumen N, Ost P, Decaestecker K, PATTYN E, Villeirs G. Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA. CLINICAL RADIOLOGY. 2017;72(1):23–32.
IEEE
[1]
P. De Visschere, N. Lumen, P. Ost, K. Decaestecker, E. PATTYN, and G. Villeirs, “Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA,” CLINICAL RADIOLOGY, vol. 72, no. 1, pp. 23–32, 2017.
@article{8168113,
  author       = {De Visschere, Pieter and Lumen, Nicolaas and Ost, Piet and Decaestecker, Karel and PATTYN, EVA and Villeirs, Geert},
  issn         = {0009-9260},
  journal      = {CLINICAL RADIOLOGY},
  keywords     = {MULTIPARAMETRIC MRI,REFERENCE-STANDARD,GUIDED BIOPSIES,SCORING SYSTEM,LOCALIZATION,METAANALYSIS,COHORT,PERFORMANCE,VALIDATION,GUIDELINES},
  language     = {eng},
  number       = {1},
  pages        = {23--32},
  title        = {Dynamic contrast-enhanced imaging has limited added value over T2-weighted imaging and diffusion-weighted imaging when using PI-RADSv2 for diagnosis of clinically significant prostate cancer in patients with elevated PSA},
  url          = {http://dx.doi.org/10.1016/j.crad.2016.09.011},
  volume       = {72},
  year         = {2017},
}

Altmetric
View in Altmetric
Web of Science
Times cited: